ImmunoCAP Allergy

ImmunoCAP Specific IgE Test: Worldwide gold standard in in vitro allergy diagnostics² designed to aid providers in the diagnosis of allergic diseases including allergic asthma, allergic rhinitis, and food allergies, with more than 550 whole allergens and allergen mixes, and 100 allergen components available.

Our mission is to provide clinically relevant and clinically accurate tests and services to enable clinicians to improve the diagnosis and management of patients with allergic disease and asthma. ImmunoCAP™ tests can be run on reliable and automated Phadia™ Laboratory Systems, which feature scalable instrument solutions for different throughput needs.

Description

Gold standard testing technology you can trust

As pioneers in allergy diagnostics we have more than 50 years of experience in allergen production and specific IgE product development Our products are documented in more than 6,000 publications² and referenced in multiple health guidelines. These may be some of the reasons for ImmunoCAP being acknowledged as the gold standard technology¹ for specific IgE blood testing.

Designed to Offer High Performance and Reliable Results

ImmunoCAP blood tests are sandwich tests, which means that the solid phase ensures binding of all relevant antibodies. This is achieved through an optimized amount of cellulose material with a very large surface area providing a uniquely high binding capacity in each ImmunoCAP test.

The ImmunoCAP Menu

In addition, ImmunoCAP tests offer your laboratory the ability to provide clinicians with fully quantitative measurement and reproducibility. This benefit is possible because our tests are linear and have low limits of quantification.

ImmunoCAP Allergy